Effectiveness of CRD-740 in Heart Failure

Stopped Part A of the study was successfully concluded. Part B of the study was not conducted in favor of redesigned new studies.

Conditions

• Heart Failure
• Heart Failure With Reduced Ejection Fraction
• Heart Failure With Preserved Ejection Fraction
• Cardiovascular Diseases
• Heart Diseases

Interventions

• DRUG: CRD-740
• DRUG: Placebo

Sponsor

Cardurion Pharmaceuticals, Inc.